1. NHS, Fungal Nail Infection [Last accessed June 2017]
  2. Sigurgeirsson et al. 2013. The prevalence of onychomycosis in the global population – A literature study. JEADV; 28:11
  3. Ameen et al. 2014. British Association of Dermatologists’ guidelines for the management of onychomycosis BJD; 171:937–958
  4. Kreijkamp-Kaspers et al. 2012. Oral antifungal medication for toenail onychomycosis (Protocol). Cochrane Review; Issue 8
  5. Drake et al. 1998. Effect of onychomycosis on quality of life. J Am Acad Dermatology; 38(5):702–704
  6. Szepietowskieti et al. 2007. Do fungi play a role in psoriatic nails? Mycoses; 50(6):437–442
  1. Roberts et al. 2003. Guidelines for treatment of onychomycosis. BJD; 148:402–410
  2. Hay et al. 2011. Onychomycosis: a proposed revision of the clinical classification. J Am Acad Dermatol; 65(6):1219–27
  3. Tietz et al. Mycoses. 2013; 56:414–421
  4. Heald AH, O'Halloran DJ, Richards K, Webb F, Jenkins S, Hollis S, et al. Fungal infection of the diabetic foot: two distinct syndromes. Diabet Med. 2001;18(7):567-72.
  5. Quirke M, Ayoub F, McCabe A, Boland F, Smith B, O'Sullivan R, et al. Risk factors for nonpurulent leg cellulitis: a systematic review and meta-analysis. Br J Dermatol. 2017;177(2):382-94.
  6. Menz H. Foot problems in older people. London: Elsevier; 2008.
  7. Gupta et al. 2000. Prevalence and epidemiology of onychomycosis in patients visiting physicians' offices: a multicenter canadian survey of 15,000 patients. J Am Acad Dermatol. 43:244-8. 

Information on this site is intended for UK Healthcare Professionals only.
Are you a UK Healthcare Professional?